Total Funding
93
79
Total FundingSeries B raised
Growth Score
4 pts
Heat Score
19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9373
Retia is medical device company that develops and sells software and hardware for patient monitoring.
Ramakrishna Mukkamala: Co-FounderPast Role: Michigan State University, Associate Professor- Tanvi Gangal: Research InternPast Role: SurgeryEdu, Team Member
About the Company
Retia Medical develops monitors for high-risk patients. Retia’s first product monitors cardiac output, a critical health metric that indicates the flow rate of blood pumped by the heart. The initial target market for this technology is the ICU and perating rooms. It is potentially extendable for use in emergency rooms or at home. Based in East
Lansing, MI, Retia’s technology was exclusively licensed from MSU and validated through extensive
tests in animals and humans. With the support of the Pritzker/Vlock family office and a strong advisory board
composed of industry and clinical experts, Retia will seek FDA approval and launch this product, which will help revolutionize the care of our most at-risk patients.
